OMC
LNAI

Old Mission Capital’s Lunai Bioworks LNAI Stock Holding History

Old Mission Capital’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-403
Closed -$18.3K – 1524
2023
Q2 		$18.3K Buy
+403
New +$30.9K ﹤0.01% 1225
2022
Q1 		– Sell
-162
Closed -$94K – 1543
2021
Q4 		$94K Buy
+162
New +$118K ﹤0.01% 932

Other funds holding LNAI

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Old Mission Capital's LNAI Position: Q3 2023 in Review

Old Mission Capital sold out of Lunai Bioworks (LNAI) in Q3 2023, closing a stake of 403 shares — an estimated $18.3K sold.

Old Mission Capital first reported a position in LNAI in Q4 2021 and held it in 2 quarters. The position peaked at $94K in Q4 2021. 21 funds tracked by Wall St. Rank hold LNAI as of Q3 2023.

  • Old Mission Capital reported no remaining Lunai Bioworks position as of Q3 2023 after selling out during the quarter.
  • Old Mission Capital sold 403 Lunai Bioworks shares in Q3 2023, an estimated $18.3K.
  • Old Mission Capital first reported a position in Lunai Bioworks in Q4 2021 and held it in 2 quarters.
  • Old Mission Capital's Lunai Bioworks position peaked at $94K in Q4 2021.
  • 21 funds tracked by Wall St. Rank held Lunai Bioworks as of Q3 2023.

Based on Old Mission Capital's 13F filing for Q3 2023, filed 15 Nov 2023.